comparemela.com

Latest Breaking News On - Health pharm generalproteomics international laboratories ltd - Page 4 : comparemela.com

Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD US Reimbursement Price & Aus Regulatory Decision

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce a major milestone in the commercialisation of its predictive test for diabetic kidney disease, PromarkerD, with the US Centers for Medicare & Medicaid Services.

Western australiaUnited statesRichard lipscombeAustralian therapeutic goods administrationAmerican medical associationUs centers for medicare medicaid servicesMedicare advisory panel on clinical diagnostic laboratoryProteomic internationalCptr proprietary laboratory analysesProteomics internationalProteomics international laboratories ltdJanssen research developmentCenters for medicare medicaid servicesLaboratory developed testTherapeutic goods administration australiaProteomics international laboratories

Proteomics International Laboratories Ltd (ASX:PIQ) New Oesophageal Cancer Test Presented at Global Conference

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce its latest results for its novel blood test for oesophageal adenocarcinoma will be presented tomorrow at the 19th ISDE World Congress for Esophageal Diseases.

United statesWestern australiaRichard lipscombeProteomics internationalProgression of barrett esophagus to cancer networkLaboratory developed testProteomics international laboratories ltdSummary of the diagnostic test developmentUs laboratory developed testEconomic health benefitOchsner health systemInternational society for diseases of the esophagusWorld congressProteomics international laboratoriesEsophageal diseasesOesophageal cancer test presented

Proteomics International Laboratories Ltd (ASX:PIQ) OxiDx Platform Technology Secures Patent in Japan

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce that its subsidiary OxiDx Pty Ltd has been granted a patent in Japan for its platform technology to measure oxidative stress.

Western australiaRichard lipscombeIan brownProteomics international laboratoriesProteomics internationalUniversity of western australiaOxidx pty ltdProteomics international laboratories ltdHorse racing industriesInternational laboratories ltdProfessional sportsHorse racingDuchenne muscularInternational laboratoriesClinical trialsHealth pharm generalproteomics international laboratories ltd

Proteomics International Laboratories Ltd (ASX:PIQ) Annual Report to Shareholders

It has been a pivotal year for Proteomics International Laboratories Ltd (ASX:PIQ), with the signing of a landmark deal to bring our PromarkerD test for diabetic kidney disease to patients in the United States.

United statesWestern australiaUnited kingdomProteomics international laboratoriesProteomics international laboratories ltdProteomics internationalAnnual reportMedtech innovation briefingInternational laboratoriesHealth pharm generalproteomics international laboratories ltdAsx piq

Proteomics International Laboratories Ltd (ASX:PIQ) Proteomics Presents at 17th Bioshares Biotech Summit

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of the presentation to be provided by Dr Richard Lipscombe to delegates at the 17th Bioshares Biotech Summit on 25 July 2023.

Western australiaRichard lipscombeProteomics international laboratoriesProteomics international laboratories ltdProteomics internationalBioshares biotechInternational laboratories ltdBioshares biotech summitInternational laboratoriesHealth pharm generalproteomics international laboratories ltdAsx piq

vimarsana © 2020. All Rights Reserved.